(EMAILWIRE.COM, July 20, 2018 ) Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships & collaborations, increasing adoption of NGS among research laboratories and academic institutes, and the decline in the cost of sequencing are driving the growth of the next-generation sequencing market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the next-generation sequencing market.

Download FREE PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=546

Geographically, the next-generation sequencing market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is estimated to command the largest share of the next-generation sequencing market in 2017, followed by Europe and Asia-Pacific. Emerging markets, like China, India, and Brazil are expected to offer significant growth opportunities owing to the improving healthcare infrastructure, government funding for translational research, and rising partnerships & agreements among market players. In addition, these countries have less-stringent regulations and data requirements as compared to developed nations; companies find regulatory policies in the Asia-Pacific region to be adaptive and business-friendly. Moreover, increasing competition in mature markets will intensify the focus on emerging markets.

As of 2016, Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.), hold the leading position in the global next-generation sequencing market. In the past three years, these companies adopted product launches & product enhancements, agreements, collaborations, and partnerships as their key business strategies to ensure market dominance. QIAGEN N. V. (Germany), BGI (China), Oxford Nanopore Technologies, Ltd. (U.K.), PerkinElmer, Inc. (U.S.), GATC Biotech AG (Germany), Agilent Technologies, Inc. (U.S.), Roche Holding AG (Switzerland), Macrogen, Inc. (South Korea), and Eurofins Scientific (Luxembourg) are some of the other major players in the next-generation sequencing market.

Read More: https://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html